NATALIE COBB: Open Payments
NPI 1174160089 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 70 payments from 13 companies in 2025. Trend: 2023 $1,435 · 2024 $1,551 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $326 |
| AstraZeneca Pharmaceuticals LP | 11 | $285 |
| PFIZER INC. | 12 | $199 |
| Eisai Inc. | 3 | $154 |
| Lilly USA, LLC | 3 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Novo Nordisk Inc | 3 | $48 |
| Dexcom, Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $35 |
| Amgen Inc. | 2 | $29 |
Products named: AIRSUPRA, Leqembi, VRAYLAR, QULIPTA, PREVNAR 20, UBRELVY, NURTEC ODT, FARXIGA.
Industry payments across AR — which companies pay providers there.
